Guggenheim Maintains Buy on Exelixis, Raises Price Target to $33
Exelixis, Inc. +0.82%
Exelixis, Inc. EXEL | 35.80 | +0.82% |
Guggenheim analyst Michael Schmidt maintains Exelixis (NASDAQ:
EXEL) with a Buy and raises the price target from $32 to $33.